Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (511-520 of 642) with videos related to

Pageof 65
Sort By:
European Heart Journal. Acute Cardiovascular Care|January 21, 2020
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care AssociationJanina Stepinska, Maddelena Lettino, Ingo Ahrens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Pharmacologic modulation of intracellular Na<sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and miceMax Lenz, Manuel Salzmann, Cosmin I Ciotu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2024
Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution in MiceJulia B Kral-Pointner, Patrick Haider, Petra L Szabo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
Journal of the American College of Cardiology|May 7, 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER TrialPascal Vranckx, Harvey D White, Zhen Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
JAMA Cardiology|April 30, 2020
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical TrialStephen D Wiviott, Robert P Giugliano, David A Morrow, et al.
European Heart Journal|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
Cardiovascular Diagnosis and Therapy|July 23, 2021
Improved in-hospital outcome for radial access in a large contemporary cohort of primary percutaneous coronary interventionMatthias Hasun, Jakob Dörler, Hannes F Alber, et al.
European Heart Journal. Acute Cardiovascular Care|August 31, 2016
Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care AssociationFrancois Schiele, Chris P Gale, Eric Bonnefoy, et al.
Pageof 65

Showing results (511-520 of 642) with videos related to

Sort By:
Pageof 65
European Heart Journal. Acute Cardiovascular Care|January 21, 2020
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care AssociationJanina Stepinska, Maddelena Lettino, Ingo Ahrens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Pharmacologic modulation of intracellular Na<sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and miceMax Lenz, Manuel Salzmann, Cosmin I Ciotu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2024
Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution in MiceJulia B Kral-Pointner, Patrick Haider, Petra L Szabo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
Journal of the American College of Cardiology|May 7, 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER TrialPascal Vranckx, Harvey D White, Zhen Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
JAMA Cardiology|April 30, 2020
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical TrialStephen D Wiviott, Robert P Giugliano, David A Morrow, et al.
European Heart Journal|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
Cardiovascular Diagnosis and Therapy|July 23, 2021
Improved in-hospital outcome for radial access in a large contemporary cohort of primary percutaneous coronary interventionMatthias Hasun, Jakob Dörler, Hannes F Alber, et al.
European Heart Journal. Acute Cardiovascular Care|August 31, 2016
Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care AssociationFrancois Schiele, Chris P Gale, Eric Bonnefoy, et al.
Pageof 65